{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:55:44Z","timestamp":1788371744842,"version":"build-2803163510"},"reference-count":47,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"IO Biotech ApS"},{"name":"National cancer for cancer Immune Therapy, Herlev Hospital","award":["Basic support from Center"],"award-info":[{"award-number":["Basic support from Center"]}]},{"DOI":"10.13039\/501100005275","name":"Region Hovedstaden","doi-asserted-by":"publisher","award":["Research agreement between the capital region of Denmark and IO Biotech"],"award-info":[{"award-number":["Research agreement between the capital region of Denmark and IO Biotech"]}],"id":[{"id":"10.13039\/501100005275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["OncoImmunology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1080\/2162402x.2021.1975889","type":"journal-article","created":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T08:44:35Z","timestamp":1632559475000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma"],"prefix":"10.1080","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8932-0374","authenticated-orcid":false,"given":"Uffe","family":"Klausen","sequence":"first","affiliation":[{"name":"Herlev Hospital","place":["Herlev, Denmark"]},{"name":"Rigshospitalet","place":["Copenhagen, Denmark"]},{"name":"National Center for Cancer Immune Therapy (CCIT-DK)","place":["Herlev, Denmark"]},{"name":"Institute for Immunology and Microbiology, Copenhagen University","place":["Copenhagen K, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai","family":"Gr\u00f8nne Dahlager J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Herlev Hospital","place":["Herlev, Denmark"]},{"name":"National Center for Cancer Immune Therapy (CCIT-DK)","place":["Herlev, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob Handlos","family":"Grauslund","sequence":"additional","affiliation":[{"name":"National Center for Cancer Immune Therapy (CCIT-DK)","place":["Herlev, Denmark"]},{"name":"Institute for Immunology and Microbiology, Copenhagen University","place":["Copenhagen K, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamaila","family":"Munir Ahmad","sequence":"additional","affiliation":[{"name":"National Center for Cancer Immune Therapy (CCIT-DK)","place":["Herlev, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Ortved","family":"Gang","sequence":"additional","affiliation":[{"name":"Rigshospitalet","place":["Copenhagen, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Martinenaite","sequence":"additional","affiliation":[{"name":"National Center for Cancer Immune Therapy (CCIT-DK)","place":["Herlev, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stine Emilie","family":"Weis-Banke","sequence":"additional","affiliation":[{"name":"National Center for Cancer Immune Therapy (CCIT-DK)","place":["Herlev, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Fredslund","family":"Breinholt","sequence":"additional","affiliation":[{"name":"Herlev Hospital","place":["Herlev, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy Wayne","family":"Novotny","sequence":"additional","affiliation":[{"name":"Herlev Hospital","place":["Herlev, Denmark"]},{"name":"Herlev Hospital","place":["Herlev, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Westerlin","family":"Kjeldsen","sequence":"additional","affiliation":[{"name":"National Center for Cancer Immune Therapy (CCIT-DK)","place":["Herlev, Denmark"]},{"name":"Institute for Immunology and Microbiology, Copenhagen University","place":["Copenhagen K, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Orebo Holmstr\u00f6m","sequence":"additional","affiliation":[{"name":"National Center for Cancer Immune Therapy (CCIT-DK)","place":["Herlev, Denmark"]},{"name":"Institute for Immunology and Microbiology, Copenhagen University","place":["Copenhagen K, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone Bredo","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Rigshospitalet","place":["Copenhagen, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Bj\u00f8rn","family":"Poulsen","sequence":"additional","affiliation":[{"name":"Zealand University Hospital","place":["Roskilde, Rosklide, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Boye","family":"Hansen","sequence":"additional","affiliation":[{"name":"Zealand University Hospital","place":["Roskilde, Rosklide, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3256-7592","authenticated-orcid":false,"given":"\u00d6zcan","family":"Met","sequence":"additional","affiliation":[{"name":"National Center for Cancer Immune Therapy (CCIT-DK)","place":["Herlev, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-6037","authenticated-orcid":false,"given":"Inge Marie","family":"Svane","sequence":"additional","affiliation":[{"name":"National Center for Cancer Immune Therapy (CCIT-DK)","place":["Herlev, Denmark"]},{"name":"Institute for Immunology and Microbiology, Copenhagen University","place":["Copenhagen K, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9880-5242","authenticated-orcid":false,"given":"Carsten Utoft","family":"Niemann","sequence":"additional","affiliation":[{"name":"Rigshospitalet","place":["Copenhagen, Denmark"]},{"name":"Institute for Immunology and Microbiology, Copenhagen University","place":["Copenhagen K, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars M\u00f8ller","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Herlev Hospital","place":["Herlev, Denmark"]},{"name":"Rigshospitalet","place":["Copenhagen, Denmark"]},{"name":"Zealand University Hospital","place":["Roskilde, Rosklide, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2914-9605","authenticated-orcid":false,"given":"Mads Hald","family":"Andersen","sequence":"additional","affiliation":[{"name":"National Center for Cancer Immune Therapy (CCIT-DK)","place":["Herlev, Denmark"]},{"name":"Institute for Immunology and Microbiology, Copenhagen University","place":["Copenhagen K, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,9,25]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-018-0696-7"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.008"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09054.x"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI63186"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.7534"},{"issue":"1","key":"e_1_3_4_7_1","article-title":"Clinical efficacy and safety of anti-PD-1\/PD-L1 inhibitors for the treatment of advanced or metastatic cancer: a systematic review and meta-analysis","volume":"10","author":"Sun L","year":"2020","unstructured":"Sun L, Zhang L, Yu J, Zhang Y, Pang X, Ma C, et al. Clinical efficacy and safety of anti-PD-1\/PD-L1 inhibitors for the treatment of advanced or metastatic cancer: a systematic review and meta-analysis. Sci Rep. 2020; 10(1): (article number 2083)","journal-title":"Sci Rep"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-421826"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1026530"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02365"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830310215"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv154"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1390641"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.261"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-3507"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.4161\/onci.23991"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.118"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1390641"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2014.50"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1560"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02145"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.595035"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.2278"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(97)00182-8"},{"key":"e_1_3_4_26_1","first-page":"199","article-title":"MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR","author":"Pott C","year":"2019","unstructured":"Pott C, Br\u00fcggemann M, Ritgen M, van der Velden VHJ, van Dongen JJM, Kneba M. MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR. In: K\u00fcppers R, editor. Methods in Molecular Biology. (Humana Press, New York, NY); 2019. p.199\u2013228.","journal-title":"In: K\u00fcppers R, editor. Methods in Molecular Biology. (Humana Press, New York, NY)"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404586"},{"key":"e_1_3_4_28_1","first-page":"185","volume-title":"Response determination criteria for ELISPOT: Toward a standard that can be applied across laboratories","author":"Moodie Z, Price L, Janetzki S, Britten CM","year":"2012","unstructured":"Moodie Z, Price L, Janetzki S, Britten CM. Response determination criteria for ELISPOT: Toward a standard that can be applied across laboratories. Methods Mol Biol. 2012; 792 185\u2013196."},{"key":"e_1_3_4_29_1","first-page":"159","volume-title":"Safety and tolerability evaluation of the use of Montanide ISATM51 as vaccine adjuvant: A systematic review. Vol. 12, Human Vaccines and Immunotherapeutics","author":"Van Doorn E","year":"2016","unstructured":"Van Doorn E, Liu H, Huckriede A, Hak E. Safety and tolerability evaluation of the use of Montanide ISATM51 as vaccine adjuvant: A systematic review. Vol. 12, Human Vaccines and Immunotherapeutics. Taylor and Francis Inc; 2016. p. 159\u2013169."},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2458"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.06.478"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-50029-y"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2019.0144"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-718528"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5"},{"key":"e_1_3_4_36_1","first-page":"619","volume-title":"Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms. Vol. 4, Expert Review of Hematology","author":"Tesfa D","year":"2011","unstructured":"Tesfa D, Palmblad J. Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms. Vol. 4, Expert Review of Hematology. Taylor & Francis; 2011. p. 619\u2013625."},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.2174\/1871529X15666150108113236"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040911"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-009-0782-8"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-009-0782-8"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.7557"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.07.012"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-198580"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002944"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.06.478"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2479"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14110-4"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70027-0"}],"container-title":["OncoImmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/2162402X.2021.1975889","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T22:55:45Z","timestamp":1766098545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/2162402X.2021.1975889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1080\/2162402X.2021.1975889"],"URL":"https:\/\/doi.org\/10.1080\/2162402x.2021.1975889","relation":{},"ISSN":["2162-402X"],"issn-type":[{"value":"2162-402X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=koni20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=koni20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-08-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"1975889"}}